Human umbilical cord-derived mesenchymal stromal cells improve left ventricular function, perfusion, and remodeling in a porcine model of chronic myocardial ischemia

Stem Cells Translational Medicine

Volumn 5, Issue 8, 2016, Pages 1004-1013

  Liu, Chuan Bin ^a   Huang, He ^b   Sun, Ping ^c   Ma, Shi Ze ^c   Liu, An Heng ^a   Xue, Jian ^a   Fu, Jin Hui ^a   Liang, Yu Qian ^c   Liu, Bing ^a   Wu, Dong Ying ^c   Lü, Shuang Hong ^a   Zhang, Xiao Zhong ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c Ivy Institute of Stem Cells Company Limited   (China)

Author keywords

Chronic myocardial ischemia; Ischemic heart disease; Mesenchymal stromal cells; Umbilical cord; Ventricular remodeling

Indexed keywords

ANGIOPOIETIN; COLLAGEN; MESSENGER RNA; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; VASCULOTROPIN; VON WILLEBRAND FACTOR; ANGIOGENIC PROTEIN; BIOLOGICAL MARKER; CYTOKINE;

ANGIOCARDIOGRAPHY; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENGRAFTMENT; FEMALE; FIBROSIS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MESENCHYMAL STROMA CELL; NONHUMAN; PIG; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUNEL ASSAY; ANIMAL; CARDIAC MUSCLE; CELL CULTURE; CELL SURVIVAL; CONVALESCENCE; CORONARY ARTERY BLOOD FLOW; CYTOLOGY; DISEASE MODEL; HEART CONTRACTION; HEART STROKE VOLUME; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; TIME FACTOR; UMBILICAL CORD; WHARTON JELLY;

ANGIOGENIC PROTEINS; ANIMALS; APOPTOSIS; BIOMARKERS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; COLLATERAL CIRCULATION; CORONARY CIRCULATION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; RECOVERY OF FUNCTION; STROKE VOLUME; SWINE; TIME FACTORS; UMBILICAL CORD; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING; VON WILLEBRAND FACTOR; WHARTON JELLY;

EID: 84978715642     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2015-0298     Document Type: Article

References (32)

1. Giusti II, Rodrigues CG, Salles FB et al. High doses of vascular endothelial growth factor 165 safely, but transiently, improve myocardial perfusion in no-option ischemic disease. Hum Gene Ther Methods 2013;24:298–306.
2. Sato T, Iso Y, Uyama T et al. Coronary vein infusion of multipotent stromal cells from bone marrow preserves cardiac function in swine ischemic cardiomyopathy via enhanced neovascularization. Lab Invest 2011;91:553–564.
3. Bolli R, Tang XL, Sanganalmath SK et al. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 2013;128:122–131.
4. Assmus B, Leistner DM, Schächinger V et al. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: Migratory capacity of administered cells determines event-free survival. Eur Heart J 2014;35:1275–1283.
5. van Ramshorst J, Rodrigo SF, Schalij MJ et al. Bone marrow cell injection for chronic myocardial ischemia: The past and the future. J Cardiovasc Transl Res 2011;4:182–191.
6. Williams AR, Suncion VY, McCall F et al. Durable scar size reduction due to allogeneic mesenchymalstemcelltherapyregulateswhole-chamber remodeling. J Am Heart Assoc 2013;2: e000140.
7. Hare JM, Traverse JH, Henry TD et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009;54:2277–2286.
8. Fadini GP, Miorin M, Facco M et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005;45: 1449–1457.
9. Heiss C, Keymel S, Niesler U et al. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005; 45:1441–1448.
10. Vassalli G, Moccetti T. Cardiac repair with allogeneic mesenchymal stem cells after myocardial infarction. Swiss Med Wkly 2011; 141:13209.
11. Le Blanc K, Frassoni F, Ball L et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 2008;371:1579–1586.
12. Zhang Z, Lin H, Shi M et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 2012; 27(suppl 2):112–120.
13. Chao KC, Chao KF, Fu YS et al. Islet-like clusters derived from mesenchymal stem cells in Wharton’s jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS One 2008;3:e1451.
14. Gao LR, Chen Y, Zhang NK et al. Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: Double-blind, randomized controlled trial. BMC Med 2015;13:162.
15. Song L, Yang YJ, Dong QT et al. Atorvasta-tin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase. PLoS One 2013;8:e65702.
16. Montanucci P, Basta G, Pescara T et al. New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly. Tissue Eng Part A 2011;17:2651–2661.
17. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284: 143–147.
18. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315–317.
19. Kimura M, Toyoda M, Gojo S et al. Allogeneic amniotic membrane-derived mesenchymal stromalcell transplantation inaporcine modelof chronic myocardial ischemia. J Stem Cells Regen Med 2012;8:171–180.
20. Muzzarelli S, Pfisterer ME, Müller-Brand J et al. Interrelation of ST-segment depression during bicycle ergometry and extent of myocardial ischaemia by myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging 2009;36: 1842–1850.
21. Abaci A, Oğuzhan A, Kahraman S et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999;99: 2239–2242.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402–408.
23. Latifpour M, Nematollahi-Mahani SN, Deilamy M et al. Improvement in cardiac function following transplantation of human umbilical cord matrix-derived mesenchymal cells. Cardiology 2011;120:9–18.
24. Zhang W, Liu XC, Yang L et al. Wharton’s jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction. Coron Artery Dis 2013;24: 549–558.
25. Templin C, Lüscher TF, Landmesser U. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments. Int J Dev Biol 2011;55: 407–417.
26. Perin EC, Silva GV, Assad JA et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol 2008;44:486– 495.
27. Freyman T, Polin G, Osman H et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006;27:1114–1122.
28. van der Spoel TI, Vrijsen KR, Koudstaal S et al. Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: A study on delivery efficiency. J Cell Mol Med 2012; 16:2768–2776.
29. Lee RH, Pulin AA, Seo MJ et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009;5:54–63.
30. Sürder D, Radrizzani M, Turchetto L et al. Combined delivery of bone marrow-derived mononuclear cells in chronic ischemic heart disease: Rationale and study design. Clin Cardiol 2013;36:435–441.
31. Chou SH, Lin SZ, Kuo WW et al. Mesenchymal stem cell insights: Prospects in cardiovascular therapy. Cell Transplant 2014;23: 513–529.
32. Quevedo HC, Hatzistergos KE, Oskouei BN et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 2009;106: 14022–14027.